Access Engineering PLC (COSE:AEL.N0000)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions LKR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	60,600	38,500	22,600	14,200	15,000	22,100
Market Cap Growth	70.35%	70.35%	59.16%	-5.33%	-32.13%	67.42%
Enterprise Value	88,342	66,070	40,861	37,253	29,828	30,989
Last Close Price	60.60	37.50	20.38	12.48	12.41	17.70
PE Ratio	10.15	6.45	3.29	5.72	2.94	9.26
Forward PE	12.92	2.84	2.84	2.84	3.79	10.51
PS Ratio	1.77	1.12	1.05	0.69	0.38	0.93
PB Ratio	1.44	0.91	0.59	0.44	0.49	0.83
P/TBV Ratio	1.54	0.98	0.64	0.49	0.56	0.98
P/FCF Ratio	-	-	5.46	1.08	-	2.94
P/OCF Ratio	-	-	5.04	1.04	-	2.59
EV/Sales Ratio	2.58	1.93	1.90	1.81	0.75	1.30
EV/EBITDA Ratio	8.15	6.21	6.31	8.45	6.26	8.42
EV/EBIT Ratio	9.13	6.91	7.62	11.74	8.27	11.63
EV/FCF Ratio	-13.96	-	9.88	2.83	-	4.12
Debt / Equity Ratio	0.66	0.66	0.57	0.57	0.77	0.36
Debt / EBITDA Ratio	2.59	2.59	3.30	4.04	4.87	2.54
Debt / FCF Ratio	-	-	5.25	1.39	-	1.25
Asset Turnover	0.33	0.33	0.24	0.25	0.57	0.45
Inventory Turnover	0.97	0.97	0.78	0.96	2.94	2.32
Quick Ratio	0.50	0.50	0.54	0.54	1.01	0.94
Current Ratio	1.17	1.17	1.13	1.11	1.62	1.46
Return on Equity (ROE)	14.82%	14.82%	19.52%	7.78%	17.95%	9.40%
Return on Assets (ROA)	5.75%	5.75%	3.70%	2.41%	3.27%	3.14%
Return on Capital (ROIC)	9.20%	9.20%	6.08%	3.80%	5.01%	4.63%
Return on Capital Employed (ROCE)	14.40%	14.40%	9.10%	6.60%	6.90%	7.60%
Earnings Yield	9.86%	15.51%	30.36%	17.48%	34.07%	10.79%
FCF Yield	-10.45%	-16.44%	18.31%	92.60%	-57.04%	34.01%
Dividend Yield	3.32%	5.33%	7.36%	-	8.06%	5.65%
Payout Ratio	33.49%	33.49%	7.29%	30.22%	14.68%	20.96%
Buyback Yield / Dilution	-0.04%	-0.04%	-	-	-	-
Total Shareholder Return	3.28%	5.29%	7.36%	-	8.06%	5.65%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.